Picture of Avalo Therapeutics logo

AVTX — Avalo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Avalo Reports Third Quarter 2024 Financial Results And Recent Business Updates

Nov 7 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND
RECENT
BUSINESS UPDATES
    * AVALO THERAPEUTICS: CASH AND CASH EQUIVALENTS WERE $81.9
MILLION
AS OF SEPTEMBER 30, 2024

Source text:  ID:nGNX9XBMm5 
Further company coverage:  AVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Avalo Therapeutics

See all news